Preferential phosphodiesterase inhibition as a novel strategy to modulate key pathways in systemic sclerosis
Systemic sclerosis (SSc) is a complex autoimmune disease marked by vasculopathy, immune dysregulation, and progressive fibrosis of the skin and internal organs. The high disease burden and impact on quality of life highlight the need for therapies that…